ArticleActa orthopaedica2026
Survivorship and risk factors for revision after total hip arthroplasty in patients 30 years and younger: a cohort study from the German arthroplasty register.
Article in Acta orthopaedica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial: The value of arthroplasty registries: from surveillance to societal impact.Acta orthopaedica · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background and purposeTotal hip arthroplasty (THA) in young patients is rare but increasingly performed. We aimed to analyze implant survivorship and risk factors for revision in patients aged 30 years or less after THA based on the German Arthroplasty Registry (EPRD).
methodsKaplan-Meier survival analysis and Cox proportional hazard models were used to analyze the EPRD dataset from 2013 to 2023 for factors associated with increased risk of revision. The primary outcome was first revision operation.
results1,622 primary THAs in 1,452 patients were analyzed. The mean age was 26 years (range 11-30), 908 (56%) of whom were male. The most frequent diagnosis was secondary osteoarthritis (1,146, 72%), followed by osteonecrosis (357, 22%), and hip dysplasia (53, 3.2%). Of all THAs, 1,601 (99%) were uncemented, and 1,574 (97%) received ceramic heads. The average follow-up period was 3.7 years (range 0-10.6). 47 hips were revised with a cumulative revision rate (CRR) at 8 years of 4.6% (95% confidence interval [CI] 2.8-7.3). The most frequent revision cause was infection in 11 cases (0.7%). Increased revision risk was associated with pediatric hip disease for those with prior surgery for Perthes, HR 4.3 (CI 1.9-9.6), pelvic osteotomy HR 2.8 (CI 1.1-7.5), and a primary diagnosis of hip dysplasia, HR 3.4 (CI 1.3-8.5).
conclusionUncemented THA in young patients demonstrated a revision rate of 4.6% (CI 2.8-7.3), which we believe is a satisfactory mid-term survival. Patients with pediatric hip disease present the highest risk of revision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.